AU2001243232A1 - Topoisomerase linker-mediated amplification methods - Google Patents

Topoisomerase linker-mediated amplification methods

Info

Publication number
AU2001243232A1
AU2001243232A1 AU2001243232A AU4323201A AU2001243232A1 AU 2001243232 A1 AU2001243232 A1 AU 2001243232A1 AU 2001243232 A AU2001243232 A AU 2001243232A AU 4323201 A AU4323201 A AU 4323201A AU 2001243232 A1 AU2001243232 A1 AU 2001243232A1
Authority
AU
Australia
Prior art keywords
topoisomerase
linker
amplification methods
mediated amplification
mediated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001243232A
Inventor
Michael Felder
John Heyman
Gabor Szalai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South Carolina Research Foundation (SCRF)
Original Assignee
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invitrogen Corp filed Critical Invitrogen Corp
Publication of AU2001243232A1 publication Critical patent/AU2001243232A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6853Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855Ligating adaptors
AU2001243232A 2000-02-25 2001-02-23 Topoisomerase linker-mediated amplification methods Abandoned AU2001243232A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18485800P 2000-02-25 2000-02-25
US60184858 2000-02-25
PCT/US2001/005745 WO2001062943A1 (en) 2000-02-25 2001-02-23 Topoisomerase linker-mediated amplification methods

Publications (1)

Publication Number Publication Date
AU2001243232A1 true AU2001243232A1 (en) 2001-09-03

Family

ID=22678649

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001243232A Abandoned AU2001243232A1 (en) 2000-02-25 2001-02-23 Topoisomerase linker-mediated amplification methods

Country Status (5)

Country Link
US (1) US7078501B2 (en)
EP (1) EP1261724A4 (en)
JP (1) JP2003524422A (en)
AU (1) AU2001243232A1 (en)
WO (1) WO2001062943A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766891A (en) * 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
DE69827745T2 (en) 1997-06-12 2005-11-10 Sloan-Kettering Institute For Cancer Research COVALENT BINDING OF DNA TO RNA STRANDS CATALYSED BY VACCINIA TOPOISOMERASE
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
JP5043277B2 (en) 2000-08-21 2012-10-10 ライフ テクノロジーズ コーポレーション Molecular cloning methods and reagents used
WO2002061034A2 (en) * 2000-12-08 2002-08-08 Invitrogen Corporation Compositions and methods for rapidly generating recombinant nucleic acid molecules
US20060008817A1 (en) * 2000-12-08 2006-01-12 Invitrogen Corporation Methods and compositions for generating recombinant nucleic acid molecules
EP2287341B1 (en) 2003-12-01 2013-02-13 Life Technologies Corporation Nucleic acid molecules containing recombination sites and methods of using the same
US20060063184A1 (en) * 2004-09-09 2006-03-23 Felix Carolyn A Compositions and methods for the detection of DNA topoisomerase II complexes with DNA
CN104350067A (en) 2012-04-10 2015-02-11 牛津纳米孔技术公司 Mutant lysenin pores
KR102168813B1 (en) 2013-03-08 2020-10-22 옥스포드 나노포어 테크놀로지즈 리미티드 Enzyme stalling method
GB201313477D0 (en) 2013-07-29 2013-09-11 Univ Leuven Kath Nanopore biosensors for detection of proteins and nucleic acids
JP6749243B2 (en) * 2014-01-22 2020-09-02 オックスフォード ナノポール テクノロジーズ リミテッド Method for attaching one or more polynucleotide binding proteins to a target polynucleotide
CN106574300A (en) 2014-05-02 2017-04-19 牛津纳米孔技术公司 Method of improving the movement of a target polynucleotide with respect to a transmembrane pore
US11274333B2 (en) * 2015-05-29 2022-03-15 Molecular Cloning Laboratories (MCLAB) LLC Compositions and methods for preparing sequencing libraries
WO2016201111A1 (en) * 2015-06-09 2016-12-15 Centrillion Technology Holdings Corporation Methods for sequencing nucleic acids
CA3016245A1 (en) 2016-03-02 2017-09-08 Oxford Nanopore Technologies Limited Mutant csgg pores and their use in polynucleotide detection and characterisation
WO2017174990A1 (en) 2016-04-06 2017-10-12 Oxford Nanopore Technologies Limited Mutant pore
WO2019002893A1 (en) 2017-06-30 2019-01-03 Vib Vzw Novel protein pores

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4661450A (en) 1983-05-03 1987-04-28 Molecular Genetics Research And Development Limited Partnership Molecular cloning of RNA using RNA ligase and synthetic oligonucleotides
WO1985004898A1 (en) 1984-04-26 1985-11-07 The Australian National University An improved method of cloning double-stranded rna, and its use in the production of viral gene clones
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
CA2005252C (en) 1988-12-13 2001-07-17 Nahum Sonenberg Isolation of full-length cdna clones and capped mrna
JP2994010B2 (en) 1989-10-31 1999-12-27 財団法人相模中央化学研究所 Cloning vector plasmid, vector primer derived from the same plasmid and preparation of cdna bank using the same primer
CA2037349C (en) 1990-03-26 2008-06-17 James G. Wetmur Branch migration of nucleotides
US5162209A (en) * 1991-01-18 1992-11-10 Beth Israel Hospital Association Synthesis of full-length, double-stranded dna from a single-stranded linear dna template
JP3337748B2 (en) 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー Method for synthesizing full-length cDNA, method for producing intermediate thereof, and method for producing recombinant vector containing full-length cDNA
DE4319468C1 (en) 1993-06-11 1994-11-17 Mueller Manfred W Method for producing a deoxyribonucleic acid (DNA) strand (cDNA strand) complementary to a ribonucleic acid (RNA) molecule, and the use of the method for the analysis of RNA molecules
US5766891A (en) * 1994-12-19 1998-06-16 Sloan-Kettering Institute For Cancer Research Method for molecular cloning and polynucleotide synthesis using vaccinia DNA topoisomerase
FR2733762B1 (en) 1995-05-02 1997-08-01 Genset Sa METHOD FOR THE SPECIFIC COUPLING OF THE HAIR OF THE 5 'END OF A RNAM FRAGMENT AND PREPARATION OF RNAM AND COMPLETE DNA
US6238884B1 (en) 1995-12-07 2001-05-29 Diversa Corporation End selection in directed evolution
US6537776B1 (en) 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
US5962271A (en) 1996-01-03 1999-10-05 Cloutech Laboratories, Inc. Methods and compositions for generating full-length cDNA having arbitrary nucleotide sequence at the 3'-end
US6013440A (en) * 1996-03-11 2000-01-11 Affymetrix, Inc. Nucleic acid affinity columns
JP3346976B2 (en) * 1996-03-18 2002-11-18 理化学研究所 How to make a full-length cDNA library
CA2258570A1 (en) 1996-06-17 1997-12-24 Biodynamics Associates Method and kits for preparing multicomponent nucleic acid constructs
US6495318B2 (en) 1996-06-17 2002-12-17 Vectorobjects, Llc Method and kits for preparing multicomponent nucleic acid constructs
US5746997A (en) * 1996-10-02 1998-05-05 Epoch Pharmaceuticals, Inc. Radiohalogenation of oligonucleotides via trialkylstannylaryl conjugates
JP3441899B2 (en) 1996-11-01 2003-09-02 理化学研究所 How to make a full-length cDNA library
US5942422A (en) 1996-11-14 1999-08-24 The Trustees Of Columbia University In The City Of New York Method for generating a directed, recombinant fusion nucleic acid
US5851808A (en) * 1997-02-28 1998-12-22 Baylor College Of Medicine Rapid subcloning using site-specific recombination
US5981182A (en) * 1997-03-13 1999-11-09 Albert Einstein College Of Medicine Of Yeshiva University Vector constructs for the selection and identification of open reading frames
WO1998055502A1 (en) 1997-06-04 1998-12-10 Smithkline Beecham Corporation METHODS FOR RAPID CLONING OF FULL LENGTH cDNAs
DE69827745T2 (en) * 1997-06-12 2005-11-10 Sloan-Kettering Institute For Cancer Research COVALENT BINDING OF DNA TO RNA STRANDS CATALYSED BY VACCINIA TOPOISOMERASE
US6140086A (en) 1997-08-15 2000-10-31 Fox; Donna K. Methods and compositions for cloning nucleic acid molecules
JP4304348B2 (en) 1997-09-22 2009-07-29 独立行政法人理化学研究所 DNA isolation method
US6413776B1 (en) 1998-06-12 2002-07-02 Galapagos Geonomics N.V. High throughput screening of gene function using adenoviral libraries for functional genomics applications
WO2000012687A1 (en) 1998-08-28 2000-03-09 Invitrogen Corporation System for the rapid manipulation of nucleic acid sequences
AU3397800A (en) 1999-03-19 2000-10-09 Invitrogen Corporation Methods of obtaining full-length nucleic acid sequences using (e. coli) topoisomerase iii and its homologs
JP2002539800A (en) 1999-03-24 2002-11-26 ジーン セラピー システムズ インコーポレーテッド Method for producing transcriptionally active DNA fragment
JP2004503207A (en) 2000-02-25 2004-02-05 ストラタジーン Methods for ligating nucleic acids and molecular cloning
US20020025561A1 (en) 2000-04-17 2002-02-28 Hodgson Clague Pitman Vectors for gene-self-assembly
US20020068290A1 (en) 2000-05-31 2002-06-06 Timur Yarovinsky Topoisomerase activated oligonucleotide adaptors and uses therefor
JP5043277B2 (en) 2000-08-21 2012-10-10 ライフ テクノロジーズ コーポレーション Molecular cloning methods and reagents used
WO2002061034A2 (en) 2000-12-08 2002-08-08 Invitrogen Corporation Compositions and methods for rapidly generating recombinant nucleic acid molecules

Also Published As

Publication number Publication date
US20010044137A1 (en) 2001-11-22
EP1261724A1 (en) 2002-12-04
JP2003524422A (en) 2003-08-19
EP1261724A4 (en) 2004-08-18
WO2001062943A1 (en) 2001-08-30
US7078501B2 (en) 2006-07-18

Similar Documents

Publication Publication Date Title
AU2001228678A1 (en) Amplifier arrangement
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001243232A1 (en) Topoisomerase linker-mediated amplification methods
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2001244646A1 (en) Small drill
AU2001290931A1 (en) Ski-snowboard
AU2001232092A1 (en) Amplifier
AU2001293852A1 (en) Sulfonylguanidine
AU2001258924A1 (en) Microsatellite-aflp
AU2001281921A1 (en) Bdellosomes
AU2001266176A1 (en) Methods
AU2001267589A1 (en) Cycloalkyl - or cycloalkylmethyl-substituted 6-phenylphenanthridines
EP1188989A3 (en) Furnace device
AU2001291876A1 (en) Triazolo-epothilones
AU2001246864A1 (en) Hypotensors
AU2001292079A1 (en) Raman amplification
AU2001250536A1 (en) Methods
AU2001262711A1 (en) Cytoprotectors
AU2001260192A1 (en) Glycinamides
AU2001226668A1 (en) Crankshaft-starter-generator